about
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightTheoretical investigation of transgastric and intraductal approaches for ultrasound-based thermal therapy of the pancreas.Macromolecular therapeuticsChallenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerEvaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancerProfile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells.Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.The ins and outs of fibroblast growth factor receptor signalling.Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.EGF receptor family: twisting targets for improved cancer therapies.Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer.SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cellsTumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study.Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy.Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer.Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug ScreeningADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
P2860
Q26766075-04A21A6E-1909-468A-BF81-56B312575E48Q30357278-74DBF6ED-F323-4650-8A1A-59A8131BC429Q34079574-D52BFBE0-E0EB-4597-8D9D-3CE0C9B48632Q34431614-E4BB27BC-DE53-4D99-B9B2-BCEFD0002D00Q35797487-768FC744-1BAB-4E4B-A523-98067E592F1BQ36186223-A3168367-FCD4-464A-8C9F-D443F5BD63F6Q37007341-599E399A-0A2F-4E34-A1CE-39FFA21ED1CFQ37079133-D4320294-C683-48B6-A52E-28E8BAAA2741Q37112691-76222053-CCC9-4F6C-A333-AFC64A81C42CQ37131462-5A2A4F5F-F1AD-4FCC-AC72-6C139C5D5AE8Q37538915-B2A4738C-8C8E-484A-B216-7774D6D57F77Q37714611-F0875170-B1DC-46CC-9FAD-C752F79CE8A1Q38208062-B2F16C4A-4814-44F6-8E45-30FDD011A2B1Q38914179-E07831CC-A6A8-4293-B16F-25A1F6BD92D0Q38928332-F8B7B86C-F6F7-41C4-8DFC-D7EE6FC42695Q39228711-25201FA7-966E-4B17-A99B-B8AE1680A2B6Q39577399-5EB24247-7776-4A1F-B68F-4DC8FFB8F62CQ41367891-4BE89E51-8809-40C8-8CEB-6C0C41FCE929Q41566970-6367DB4F-8EBF-4E26-AC22-D545760552FEQ41959768-A937FE0F-71B1-4E8A-BA0A-D26D4CBC6449Q42126450-E5CC4E66-BBD8-4FBD-9CBB-FF65F079592BQ48888319-45FA6A43-6764-476A-9CA8-0E514A0C1E94Q49547506-9DD4D41A-E87A-46FD-A3CD-FF6EA6A83557Q51073566-2A01FFA1-99BB-45CD-AAB8-C2665FFBAA6DQ58695399-FE5E010C-BA77-4C17-A511-2ACC1A0EF4F8Q59137239-F43C17C3-DE2D-44B5-864C-4FE8AB419DFC
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor-stromal interactions in pancreatic cancer
@en
type
label
Tumor-stromal interactions in pancreatic cancer
@en
prefLabel
Tumor-stromal interactions in pancreatic cancer
@en
P2093
P2860
P1476
Tumor-stromal interactions in pancreatic cancer
@en
P2093
Clifford Whatcott
Daniel D Von Hoff
Haiyong Han
Richard G Posner
P2860
P304
P356
10.1615/CRITREVONCOG.V18.I1-2.80
P407
P577
2013-01-01T00:00:00Z